HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate
November 18, 2024 07:00 ET
|
HCW Biologics, Inc
HCW Biologics signed license agreement with WY Biotech
HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights
November 14, 2024 16:40 ET
|
HCW Biologics, Inc
Press release for Q3 2024 business highlights and financial results
HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights
April 01, 2024 16:10 ET
|
HCW Biologics, Inc
Q4 and Year End Earnings Release and Business Highlights
HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders
June 14, 2023 07:30 ET
|
HCW Biologics, Inc
MIRAMAR, Fla., June 14, 2023 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCW Biologics” or the “Company”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and...